Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library (2014)
- Authors:
- USP affiliated authors: YASUNAKA, JENICER KAZUMI UMADA YOKOYAMA - ICB ; ULIANA, SILVIA RENI BORTOLIN - ICB
- Unidade: ICB
- DOI: 10.1111/cbdd.12239
- Assunto: PARASITOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Chemical Biology Drug Design
- ISSN: 1747-0285
- Volume/Número/Paginação/Ano: v. 83, n. 3, p. 289-296, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BONANO, Vivian I. et al. Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library. Chemical Biology Drug Design, v. 83, n. 3, p. 289-296, 2014Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12239. Acesso em: 21 fev. 2026. -
APA
Bonano, V. I., Yokoyama-Yasunaka, J. K. U., Miguel, D. C., Jones, S. A., Dodge, J. A., & Uliana, S. R. B. (2014). Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library. Chemical Biology Drug Design, 83( 3), 289-296. doi:10.1111/cbdd.12239 -
NLM
Bonano VI, Yokoyama-Yasunaka JKU, Miguel DC, Jones SA, Dodge JA, Uliana SRB. Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library [Internet]. Chemical Biology Drug Design. 2014 ; 83( 3): 289-296.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1111/cbdd.12239 -
Vancouver
Bonano VI, Yokoyama-Yasunaka JKU, Miguel DC, Jones SA, Dodge JA, Uliana SRB. Discovery of synthetic Leishmania Inhibitors by screening of a 2-arylbenzothiophene library [Internet]. Chemical Biology Drug Design. 2014 ; 83( 3): 289-296.[citado 2026 fev. 21 ] Available from: https://doi.org/10.1111/cbdd.12239 - Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool
- Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial
- A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
- Combination therapy with Tamoxifen and Amphotericin B in experimental cutaneous Leishmaniasis
- In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B
- Topical tamoxifen in the therapy of cutaneous leishmaniasis
- Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis
- Antileishmanial activity of the estrogen receptor modulator raloxifene
- Low plasma lipids are associated with relapsing and lethal Visceral Leishmaniasis in HIV-infected patients
- Leishmania is not prone to develop resistance to tamoxifen
Informações sobre o DOI: 10.1111/cbdd.12239 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
